Why does the severity of COVID-19 differ with age?: understanding the mechanisms underlying the age gradient in outcome following SARS-CoV-2 infection
P Zimmermann, N Curtis - The Pediatric Infectious Disease …, 2022 - journals.lww.com
Although there are many hypotheses for the age-related difference in the severity of COVID-
19, differences in innate, adaptive and heterologous immunity, together with differences in …
19, differences in innate, adaptive and heterologous immunity, together with differences in …
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization
BS Johnson, M Laloraya - Cytokine & growth factor reviews, 2020 - Elsevier
The seventh human coronavirus SARS-CoV2 belongs to the cluster of extremely pathogenic
coronaviruses including SARS-CoV and MERS-CoV, which can cause fatal lower …
coronaviruses including SARS-CoV and MERS-CoV, which can cause fatal lower …
Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19
Bacillus Calmette-Guérin (BCG) vaccination may reduce the risk of a range of infectious
diseases, and if so, it could protect against coronavirus disease 2019 (COVID-19). Here, we …
diseases, and if so, it could protect against coronavirus disease 2019 (COVID-19). Here, we …
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian …
This proof-of-concept study tested if prior BCG revaccination can qualitatively and
quantitively enhance antibody and T-cell responses induced by Oxford/AstraZeneca …
quantitively enhance antibody and T-cell responses induced by Oxford/AstraZeneca …
The effect of BCG vaccination on COVID-19 examined by a statistical approach: no positive results from the Diamond Princess and cross-national differences …
M Asahara - MedRxiv, 2020 - medrxiv.org
Recently, the controversial hypothesis that BCG (Bacillus Calmette–Guérin) vaccination
reduces infection or severity of COVID-19 has been proposed. The present study examined …
reduces infection or severity of COVID-19 has been proposed. The present study examined …
[HTML][HTML] BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the …
This study tested if prior BCG revaccination can further boost immune responses
subsequently induced by a widely distributed and otherwise efficacious Oxford/AstraZeneca …
subsequently induced by a widely distributed and otherwise efficacious Oxford/AstraZeneca …
Métodos para avaliação da efetividade de vacinas para COVID-19 com ênfase em abordagens quase-experimentais
JM Pescarini, CSS Teixeira, EP Cruz… - Ciência & Saúde …, 2021 - SciELO Public Health
A avalição da efetividade de vacinas é feita com dados do mundo real e é essencial para
monitorar o desempenho dos programas de vacinação ao longo do tempo bem como frente …
monitorar o desempenho dos programas de vacinação ao longo do tempo bem como frente …
Methods to evaluate COVID-19 vaccine effectiveness, with an emphasis on quasi-experimental approaches
JM Pescarini, CSS Teixeira, EP Cruz… - Ciência & Saúde …, 2021 - SciELO Public Health
The evaluation of vaccine effectiveness is conducted with real-world data. They are
essential to monitor the performance of vaccination programmes over time, and in the …
essential to monitor the performance of vaccination programmes over time, and in the …
BCG-вакцинирование как протекция от COVID-19: эпидемиологические и молекулярно-биологические аспекты
ЯШ Шварц, НВ Ставицкая… - Туберкулез и болезни …, 2020 - tibl-journal.com
Аннотация В обзоре рассматривается недавно появившаяся гипотеза о том, что
национальная политика BCG-вакцинации влияет на распространение COVID-19 в …
национальная политика BCG-вакцинации влияет на распространение COVID-19 в …
BCG and SARS-CoV-2—What Have We Learned?
J Kulesza, E Kulesza, P Koziński, W Karpik, M Broncel… - Vaccines, 2022 - mdpi.com
Despite controversy over the protective effect of the BCG (Bacille Calmette-Guérin) vaccine
in preventing pulmonary tuberculosis (TB) in adults, it has been used worldwide since 1921 …
in preventing pulmonary tuberculosis (TB) in adults, it has been used worldwide since 1921 …